Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 26, 2022

SELL
$225.82 - $368.51 $234,175 - $382,144
-1,037 Closed
0 $0
Q3 2021

Oct 08, 2021

BUY
$221.9 - $484.47 $230,110 - $502,395
1,037 New
1,037 $399,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $16.1B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Johnson Midwest Financial, LLC Portfolio

Follow Johnson Midwest Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Midwest Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Johnson Midwest Financial, LLC with notifications on news.